Ethylene Glycol Dibutanoate

Ethylene Glycol Dibutanoate

SCHEMBL104207

CCCC(=O)OCCOC(=O)CCC

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.65
ALDH1A1 P00352 2/20 0.60
ADRA2A P08913 1/20 0.50
ADRA1A P35348 1/20 0.50
MAPT P10636 1/20 0.48
BLM P54132 1/20 0.48
DNM1 Q05193 1/20 0.47
NAAA Q02083 1/20 0.46
HTR2C P28335 1/20 0.45
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
FFAR3 O14843 2/20 0.43
HDAC3 O15379 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
PAM P19021 2/20 0.41
TSHR P16473 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15636150 0.97 DGKA (0.62) DGKAALDH1A1ADRA2AADRA1AMAPT
Ethylene Glycol Dibutanoate SCHEMBL50505 0.92 DGKA (0.58) DGKAALDH1A1ADRA2AADRA1AMAPT
Diethylene Glycol Dibutanoate SCHEMBL421383 0.92 DGKA (0.58) DGKAALDH1A1ADRA2AADRA1AMAPT
SCHEMBL29601907 0.92 DGKA (0.58) DGKAALDH1A1ADRA2AADRA1AMAPT
Triethylene Glycol Dibutanoate SCHEMBL4305344 0.92 DGKA (0.58) DGKAALDH1A1ADRA2AADRA1AMAPT
SCHEMBL181440 0.92 ALDH1A1 (0.59) DGKAALDH1A1ADRA2AADRA1AMAPT
SCHEMBL13465983 0.92 DGKA (0.58) DGKAALDH1A1ADRA2AADRA1AMAPT
SCHEMBL125157 0.92
SCHEMBL181422 0.90 ALDH1A1 (0.56) DGKAALDH1A1ADRA2AADRA1AMAPT
SCHEMBL6835296 0.90 DGKA (0.56) DGKAALDH1A1ADRA2AADRA1AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117030-A1 MODIFICATION METHOD OF POLYHYDROXYALKANOATE BEIJING PHABUILDER BIOTECHNOLOGY CO LTD (CN) 2026-04-30 US claimed
CN-120020118-A Process for preparing amides and N-vinylamides containing ether groups 中国石油化工股份有限公司 2025-05-20 CN claimed
CN-120020116-A Process for the preparation of N-alkenylamides 中国石油化工股份有限公司 2025-05-20 CN claimed
CN-120020119-A Process for preparing N- (2-substituted ethyl) amides and N-vinyl amides 中国石油化工股份有限公司 2025-05-20 CN claimed
US-20250075147-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS OSMO LABS, PBC 2025-03-06 US claimed
CN-119371305-A Method for assisting alcoholysis of waste PET (polyethylene terephthalate) methanol by using ester solvent 华东理工大学 2025-01-28 CN claimed
US-20240400784-A1 Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition LG CHEM, LTD. (KR) 2024-12-05 US claimed
US-20240392094-A1 Method for Screening Solvent for Polyvinyl Chloride Extraction, Recycling Method for Waste Material, and Recycled Polyvinyl Chloride and Composition LG CHEM, LTD. (KR) 2024-11-28 US claimed
EP-4421112-A1 METHOD FOR MODIFYING POLYHYDROXYALKANOATE Beijing Phabuilder Biotechnology Co., Ltd. (CN) 2024-08-28 EP claimed
WO-2024148825-A1 METHOD FOR MODIFYING POLYHYDROXYALKANOATE 北京微构工场生物技术有限公司 2024-07-18 WO claimed
CN-111433297-B Film-printable ultraviolet-curable ink composition, method for producing frame pattern, and display substrate 株式会社LG化学 2022-05-31 CN claimed
US-11332631-B2 Film-printable ultraviolet-ray-curable ink composition, bezel pattern manufacturing method using same, bezel pattern manufactured according to same, and display substrate including same LG CHEM, LTD. 2022-05-17 US claimed
CN-114277581-A Synthetic leather and preparation method thereof 陈永裕 2022-04-05 CN claimed
CN-109689792-B Liquid antioxidant composition for raw rubber 巴斯夫欧洲公司 2022-03-29 CN claimed
US-11084909-B2 Liquid antioxidant composition for raw rubbers BASF SE (DE) 2021-08-10 US claimed
EP-3507331-A1 A LIQUID ANTIOXIDANT COMPOSITION FOR RAW RUBBERS BASF SE (DE) 2019-07-10 EP claimed
US-20190194402-A1 A LIQUID ANTIOXIDANT COMPOSITION FOR RAW RUBBERS BASF SE (DE) 2019-06-27 US claimed
WO-2018041649-A1 A LIQUID ANTIOXIDANT COMPOSITION FOR RAW RUBBERS BASF SE (DE) 2018-03-08 WO claimed
EP-1390085-B1 HYDROGEL COMPOSITIONS AV TOPCHIEV INST PETROCHEMICAL (RU) 2009-08-05 EP claimed
EP-1680088-B1 Taste-masked formulation comprising clarithromycin SANDOZ AG (CH) 2008-12-03 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260117030-A1 MODIFICATION METHOD OF POLYHYDROXYALKANOATE PGLS, ALG1, PHAX DGKA 901/4885ALDH1A1 3712/4885ADRA2A 4327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.